Status:
COMPLETED
Long-term Pulmonary Outcomes After Infection With Sars-CoV-2
Lead Sponsor:
University of Aarhus
Conditions:
Sars-CoV2
Covid19
Eligibility:
All Genders
18-85 years
Brief Summary
The objective of this study is to assess the long-term outcomes after hospital admission with Covid-19 with respect to pulmonary function, physical capacity, imaging, quality of life and socioeconomic...
Detailed Description
Patients will be invited to follow-up visits 3 and 12 months after hospitalization with COVID19. Inclusion will take place during 2020. We expect to enroll 180 non-ICU patients and 36 ICU patients.
Eligibility Criteria
Inclusion
- Infection with Sars-CoV-2
Exclusion
- Unable to attend hospital visits due to frailty or severe disease
- Unable to understand and complete questionnaires due to intellectual or language limitations / deficits
Key Trial Info
Start Date :
June 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT04401163
Start Date
June 18 2020
End Date
August 1 2022
Last Update
May 12 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark
2
Regional Hospital, Holstebro
Holstebro, Denmark
3
Regional Hospital, Horsens
Horsens, Denmark
4
Regional Hospital, Randers
Randers, Denmark